GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Intangible Assets

ARSUF (Fagron) Intangible Assets : $534.7 Mil (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Fagron's intangible assets for the quarter that ended in Jun. 2024 was $534.7 Mil.


Fagron Intangible Assets Historical Data

The historical data trend for Fagron's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Intangible Assets Chart

Fagron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 464.60 473.44 464.49 490.89 526.63

Fagron Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 496.08 490.89 517.47 526.63 534.73

Fagron Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Fagron  (OTCPK:ARSUF) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Fagron Intangible Assets Related Terms

Thank you for viewing the detailed overview of Fagron's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

From GuruFocus

Q4 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2021 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q1 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Fagron NV Earnings Call Transcript

By GuruFocus News 10-09-2024

Q4 2021 Fagron NV Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Full Year 2019 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2023 Fagron NV Earnings Call Transcript

By GuruFocus Research 03-25-2024

Q3 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q3 2019 Fagron NV Corporate Sales Call Transcript

By GuruFocus Research 02-12-2024